Skip to Content
Merck

Actomyosin-dependent invasion of endothelial sprouts in collagen.

Cytoskeleton (Hoboken, N.J.) (2020-06-27)
Marie-Mo Vaeyens, Alvaro Jorge-Peñas, Jorge Barrasa-Fano, Apeksha Shapeti, Maarten Roeffaers, Hans Van Oosterwyck
ABSTRACT

During sprouting angiogenesis-the growth of blood vessels from the existing vasculature-endothelial cells (ECs) adopt an elongated invasive form and exert forces at cell-cell and cell-matrix interaction sites. These cell shape changes and cellular tractions require extensive reorganizations of the actomyosin network. However, the respective roles of actin and myosin for endothelial sprouting are not fully elucidated. In this study, we further investigate these roles by treating 2D-migrating and 3D-sprouting ECs with chemical compounds targeting either myosin or actin. These treatments affected the endothelial cytoskeleton drastically and reduced the invasive response in a compound-specific manner; pointing toward a tight control of the actin and myosin activity during sprouting. Clusters in the data further illustrate that endothelial sprout morphology is sensitive to the in vitro model mechanical microenvironment and directs future research toward mechanical substrate guidance as a strategy for promoting engineered tissue vascularization. In summary, our results add to a growing corpus of research highlighting a key role of the cytoskeleton for sprouting angiogenesis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
(±)-Blebbistatin, (±)-Blebbistatin, CAS 674289-55-5, is a cell-permeable, selective, and reversible inhibitor of nonmuscle myosin II. Blocks cell blebbing and disrupts cell migration & cytoKinesis in vertebrate cells.
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Collagen Type I, rat tail
SKU
Pack Size
Availability
Price
Quantity